glp-1 colorectal cancer risk study november 2025 mortality GLP-1 receptor agonists confer 'modest' protection against obesity-related cancers GLP‐1 receptor agonists and the

p = 0.02) in this population

A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial

Our results were in accordance with previous studies reported by Xin et al

When semaglutide activates these pathways, it can trigger changes in neurotransmitter release that sometimes shift circadian rhythm signals or alter how the body processes glucose during sleep

Its one of the first questions our team gets from researchers embarking on studies with this unique peptide

While switching delivery methods is unlikely to overcome a physiological plateau on its own, it can be one piece of a broader adjustment strategy